Skip to content

The evaluation of Chinese therapeutic food for the treatment of dyslipidemia

In patients with dyslipidemia, is the selected Chinese therapeutic food (specifically an extrat combining Hawthorn fruit and Chinese kiwi fruit) better than placebo, for regulating abnormal blood lipid levels?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000092291
Enrollment
60
Registered
2009-02-10
Start date
2009-02-16
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study aim is to evaluate the efficacy of selected Chinese therapeutic food (an extract combining Hawthorn fruit and Chinese Kiwi fruit) for dyslipidemia treatment. It is the hypothesized that the therapeutic food may have a positive effect on the treatment of dyslipidemia, and that it may improve participants’ general well-being.

Interventions

Intake of the therapeutic food powder(specifically an extract of Hawthorn fruit and Chinese kiwi fruit), 20g daily, for one month The extracting concentration: raw Hawthorn fruit and raw Chinese kiwi fruit: extract powder=5:1 (It means that one unit of the powder is extracted and concentrated from five units of the raw fruits)

Sponsors

Victoria University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

having lived in Australia for the past 10 years ; diagnosed with dyslipidemia (moderate level), in which fasting serum LDL-C level within 100-160mg/dL or TG within 150-250mg/dL; with blood pressure lower than 159/99mmHg

Exclusion criteria

other major medical conditions (ie. established CVD, severe diabetes, thyroid dysfunction, hepatic or renal disorders) or pregnancy; having been taking other supplements or medicine which may influence blood lipid levels in the past 3 months; allergic to the extract of the therapeutic food or wheat germ; asthma; fluid retention or severe diarrhoea; with Asian cultural background

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026